SVE
ENG

Search for:

About us
Our Science
Pipeline
Investors
Governance
Media
Contact

Search for:

May 25, 2021

Presentation at ABGSC Life Science Summit

The presentation is available here: https://youtu.be/6OLnNzeAmHE

Investors

Jeppe Øvlesen

Jeppe Øvlesen

Chief Executive Officer and Board Member

+45 28 44 75 67

[email protected]

Björn Westberg

Björn Westberg

Chief Financial Officer

[email protected]

About Synact Pharma

SynAct Pharma is a clinical stage biotechnology company focused on resolving inflammation with melanocortin biology. Selective activation of the melanocortin system can help the immune system resolve excessive or chronic inflammation.

Privacy Policy
Cookies

Explore our Website

About us
Our Science
Pipeline
Investors
Governance
Media
Contact

LinkedIn

Subscribe